Role of DNA repair systems in malignant tumor development in the elderly

Geriatrics and Gerontology International

Volumn 8, Issue 2, 2008, Pages 65-72

  Arai, Tomio ^a   Sawabe, Motoji ^a   Hosoi, Takayuki ^b   Tanaka, Noriko ^c,d  

^a Tokyo Metropolitan Institute of Gerontology   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Aging; Carcinoma; Hypermethylation; Singlenu cleotide polymorphism

Indexed keywords

MLH1 PROTEIN, HUMAN; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

AGE; AGED; AGING; ARTICLE; DNA METHYLATION; DNA REPAIR; GASTROINTESTINAL TUMOR; GENETICS; HUMAN; JAPAN; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGE FACTORS; AGED; AGING; DNA METHYLATION; DNA REPAIR; GASTROINTESTINAL NEOPLASMS; HUMANS; JAPAN; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 55749093419     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2008.00450.x     Document Type: Review

References (61)

1. DePinho RA. The age of cancer. Nature 2000; 408: 248-254.
2. Mori M, Hashimoto H, Takahashi T et al. Malignant tumors in a Japanese geriatric hospital. Nippon Ronen Igakkai Zasshi 1997; 34: 130-134. (In Japanese with English abstract.)
3. Kitagawa M, Utsuyama M, Kurata M et al. Cancer and aging: Symposium of the 27th annual meeting of the Japanese society for biomedical gerontology, Tokyo. Cancer Immunol Immunother 2005; 54: 623-634.
4. Ruttan CC, Glickman BW. Coding variants in human double-strand break DNA repair genes. Mutat Res 2002; 509: 175-200.
5. Minister's Secretariat, Statistics and Information Department, Ministry of Health, Labour and Welfare of Japan. Vital Statistics of Japan, Vol. 3. Tokyo: Health and Welfare Statistics Association, 2004; 136-153.
6. Oshima A, Kuroishi T, Tajima K. Cancer Statistics - Incidence/Mortality/ Prognosis. Tokyo: Shinohara, 2004 (In Japanese.)
7. Arai T, Takubo K, Sawabe M, Esaki Y. Pathologic characteristics of colorectal cancer in the elderly: A retrospective study of 947 surgical cases. J Clin Gastroenterol 2000; 31: 67-72.
8. Arai T, Sawabe M, Takubo K, Kanazawa K, Esaki Y. Multiple colorectal cancers in the elderly: A retrospective study of both surgical and autopsy cases. J Gastroenterol 2001; 36: 748-752.
9. Arai T, Esaki Y, Inoshita N et al. Pathologic characteristics of gastric cancer in the elderly: A retrospective study of 994 surgical patients. Gastric Cancer 2004; 7: 154-159.
10. Arai T, Takubo K. Clinicopathological and molecular characteristics of gastric and colorectal carcinomas in the elderly. Pathol Int 2007; 57: 303-314.
11. Yokozaki H, Yasui W, Tahara E. Genetic and epigenetic changes in stomach cancer. Int Rev Cytol 2001; 204: 49-95.
12. Kondo Y, Issa JP. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev 2004; 23: 29-39.
13. Nakagawa H, Nuovo GJ, Zervos EE et al. Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res 2001; 61: 6991-6995.
14. Yuasa Y. DNA methylation in cancer and ageing. Mech Ageing Dev 2002; 123: 1649-1654.
15. Ruschoff J, Dietmaier W, Luttges J et al. Poorly differentiated colonic adenocarcinoma, medullary type: Clinical, phenotypic, and molecular characteristics. Am J Pathol 1997; 150: 1815-1825.
16. Lanza G, Gafa R, Matteuzzi M, Santini A. Medullary-type poorly differentiated adenocarcinoma of the large bowel: A distinct clinicopathologic entity characterized bymicrosatellite instability and improved survival. J Clin Oncol 1999; 17: 2429-2438.
17. Miyakura Y, Sugano K, Konishi F et al. Extensive methylation of hMLH1 promoter region predominates in proximal colon cancer with microsatellite instability. Gastroenterology 2001; 121: 1300-1309.
18. Hawkins N, Norrie M, Cheong K et al. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 2002; 122: 1376-1387.
19. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994; 7: 536-540.
20. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 1998; 58: 5489-5494.
21. Nakajima T, Akiyama Y, Shiraishi J et al. Age-related hypermethylation of the hMLH1 promoter in gastric cancers. Int J Cancer 2001; 94: 208-211.
22. Kakar S, Burgart LJ, Thibodeau SN et al. Frequency of loss of hMLH1 expression in colorectal carcinoma increases with advancing age. Cancer 2003; 97: 1421-1427.
23. So K, Tamura G, Honda T et al. Multiple tumor suppressor genes are increasingly methylated with age in non-neoplastic gastric epithelia. Cancer Sci 2006; 97: 1155-1158.
24. Arai T, Esaki Y, Sawabe M, Honma N, Nakamura K, Takubo K. Hypermethylation of the hMLH1 promoter with absent hMLH1 expression in medullary-type poorly differentiated colorectal adenocarcinoma in the elderly. Mod Pathol 2004; 17: 172-179.
25. Jass JR. Pathology of hereditary nonpolyposis colorectal cancer. Ann NY Acad Sci 2000; 910: 62-74.
26. Messerini L, Vitelli F, De Vitis LR et al. Microsatellite instability in sporadic mucinous colorectal carcinomas: Relationship to clinico-pathological variables. J Pathol 1997; 182: 380-384.
27. Arai T, Kasahara I, Sawabe M et al. Microsatellite-unstable mucinous colorectal carcinoma occurring in the elderly: Comparison with medullary type poorly differentiated adenocarcinoma. Pathol Int 2007; 57: 205-212.
28. Kakar S, Aksoy S, Burgart LJ, Smyrk TC. Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survival. Mod Pathol 2004; 17: 696-700.
29. Arai T, Sugai T, Kasahara I et al. Age-related alteration in the association of microsatellite instability with absent hMLH1 expression and histological types of colorectal carcinoma. Pathol Int 2006; 56: 597-603.
30. Shinmura K, Yokota J. The OGG1 gene encodes a repair enzyme for oxidatively damaged DNA and is involved in human carcinogenesis. Antioxid Redox Signal 2001; 3: 597-609.
31. May P, May E. Twenty years of p53 research: Structural and functional aspects of the p53 protein. Oncogene 1999; 18: 7621-7636.
32. Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998; 58: 604-608.
33. Ito E, Yanagisawa Y, Iwahashi Y et al. A core promoter and a frequent single-nucleotide polymorphism of the mismatch repair gene hMLH1. Biochem Biophys Res Commun 1999; 256: 488-494.
34. Lio D, Annoni G, Licastro F et al. Tumor necrosis factor-alpha -308A/G polymorphism is associated with age at onset of Alzheimer's disease. Mech Ageing Dev 2006; 127: 567-571.
35. Menin C, Scaini MC, De Salvo GL et al. Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status. J Natl Cancer Inst 2006; 98: 285-288.
36. Hurme M, Lehtimaki T, Jylha M, Karhunen PJ, Hervonen A. Interleukin-6-174G/C polymorphism and longevity: A follow-up study. Mech Ageing Dev 2005; 126: 417-418.
37. van Heemst D, Mooijaart SP, Beekman M et al. Variation in the human TP53 gene affects old age survival and cancer mortality. Exp Gerontol 2005; 40: 11-15.
38. Hung RJ, Hall J, Brennan P, Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: A HuGE review. Am J Epidemiol 2005; 162: 925-942.
39. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11: 1513-1530.
40. Hashimoto T, Uchida K, Okayama N et al. Interaction of OGG1 Ser326Cys polymorphism with cigarette smoking in head and neck squamous cell carcinoma. Mol Carcinog 2006; 45: 344-348.
41. Fan R, Wu MT, Miller D et al. The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2000; 9: 1037-1042.
42. Matakidou A, Eisen T, Houlston RS. TP53 polymorphisms and lung cancer risk: A systematic review and meta-analysis. Mutagenesis 2003; 18: 377-385.
43. Jee SH, Won SY, Yun JE, Lee JE, Park JS, Ji SS. Polymorphism p53 codon-72 and invasive cervical cancer: A meta-analysis. Int J Gynaecol Obstet 2004; 85: 301-308.
44. Hiyama T, Tanaka S, Kitadai Y et al. p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. Int J Cancer 2002; 100: 304-308.
45. Koushik A, Tranah GJ, Ma J et al. p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer. Int J Cancer 2006; 119: 1863-1868.
46. Shen H, Zheng Y, Sturgis EM, Spitz MR, Wei Q. P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: A case-control study. Cancer Lett 2002; 183: 123-130.
47. Buyru N, Tigli H, Dalay N. P53 codon 72 polymorphism in breast cancer. Oncol Rep 2003; 10: 711-714.
48. Ratnasinghe D, Yao SX, Tangrea JA et al. Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2001; 10: 119-123.
49. Hu Z, Ma H, Chen F, Wei Q, Shen H. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 2005; 14: 1810-1818.
50. Matullo G, Dunning AM, Guarrera S et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 2006; 27: 997-1007.
51. Quintela-Fandino M, Hitt R, Medina PP et al. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy. J Clin Oncol 2006; 24: 4333-4339.
52. Biros E, Kalina I, Biros I et al. Polymorphism of the p53 gene within the codon 72 in lung cancer patients. Neoplasma 2001; 48: 407-411.
53. Zienolddiny S, Campa D, Lind H et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2006; 27: 560-567.
54. Kiyohara C, Takayama K, Nakanishi Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer 2006; 54: 267-283.
55. Sawabe M, Arai T, Kasahara I et al. Developments of geriatric autopsy database and Internet-based database of Japanese single nucleotide polymorphisms for geriatric research (JG-SNP). Mech Ageing Dev 2004; 125: 547-552.
56. Nakahara K, Matsushita S, Matsuoka H et al. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene affects heart weight. Circulation 2000; 101: 148-151.
57. Kazama H, Hosoi T, Nakahara K et al. Association between a promoter polymorphism of the paraoxonase PON1 gene and pathologically verified Parkinson's disease. Geriatr Gerontol Int 2002; 2: 91-96.
58. Kazama H, Ruberu NN, Murayama S et al. Association of estrogen receptor alpha gene polymorphisms with neurofibrillary tangles. Dement Geriatr Cogn Disord 2004; 18: 145-150.
59. Sawabe M, Takahashi R, Matsushita S et al. Aortic pulse wave velocity and the degree of atherosclerosis in the elderly: A pathological study based on 304 autopsy cases. Atherosclerosis 2005; 179: 345-351.
60. Sawabe M, Arai T, Kasahara I et al. Sustained progression and loss of the gender-related difference in atherosclerosis in the very old: A pathological study of 1074 consecutive autopsy cases. Atherosclerosis 2006; 186: 374-379.
61. Oda K, Tanaka N, Arai T et al. Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases. Hum Mol Genet 2007; 16: 592-599.